Astonea Labs Ltd — Board Meeting, 03-12-2025: Board Meeting
03-12-2025 | 07:03 pm
03-12-2025 | 07:03 pm
Board approved acquiring an equity stake in Damaira Pharmaceuticals and investing in foreign subsidiaries. Company will transition to Ind AS from FY2026-27. Mr. Ankit Kapoor appointed Company Secretary; Mr. Pardeep Singh retired as Director.
No comments yet. Be the first to comment!
